On Monday, Tenaya Therapeutics Inc (NASDAQ: TNYA) opened lower -5.31% from the last session, before settling in for the closing price of $1.13. Price fluctuations for TNYA have ranged from $0.36 to $4.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -15.48% over the last five years. Company’s average yearly earnings per share was noted 47.32% at the time writing. With a float of $137.66 million, this company’s outstanding shares have now reached $162.98 million.
The firm has a total of 97 workers. Let’s measure their productivity.
Tenaya Therapeutics Inc (TNYA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tenaya Therapeutics Inc is 15.53%, while institutional ownership is 18.01%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,711. In this transaction SVP, Finance of this company sold 2,962 shares at a rate of $1.25, taking the stock ownership to the 95,338 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Medical Officer sold 5,053 for $1.25, making the entire transaction worth $6,331. This insider now owns 172,803 shares in total.
Tenaya Therapeutics Inc (TNYA) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.3 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.37) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 82.11% during the next five years compared to -15.48% drop over the previous five years of trading.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Check out the current performance indicators for Tenaya Therapeutics Inc (TNYA). In the past quarter, the stock posted a quick ratio of 6.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Analysing the last 5-days average volume posted by the [Tenaya Therapeutics Inc, TNYA], we can find that recorded value of 4.7 million was better than the volume posted last year of 2.98 million. As of the previous 9 days, the stock’s Stochastic %D was 55.20%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 65.14%, which indicates a significant increase from 52.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1301 in the past 14 days, which was higher than the 0.0647 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7680, while its 200-day Moving Average is $1.0939. Now, the first resistance to watch is $1.1167. This is followed by the second major resistance level at $1.1633. The third major resistance level sits at $1.1967. If the price goes on to break the first support level at $1.0367, it is likely to go to the next support level at $1.0033. Now, if the price goes above the second support level, the third support stands at $0.9567.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are currently 162,976K shares outstanding in the company with a market cap of 174.39 million. Presently, the company’s annual sales total 0 K according to its annual income of -111,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -23,280 K.
